Literature DB >> 16019512

Multiple myeloma involving the central nervous system: a report of two cases with unusual manifestations.

Charalampos Pontikoglou1, Constantine Fragos, Eleftheria Kolyvaki, George Samonis, George D Eliopoulos, Helen A Papadaki.   

Abstract

We describe two patients with multiple myeloma (MM) involving the central nervous system (CNS). In both patients, CNS involvement was manifested with extremely rare signs and symptoms. The first patient, a 64-year-old woman, developed obstructive hydrocephalus 10 years after the initial diagnosis of MM. The disease has been successfully treated with intrathecal chemotherapy, radiotherapy and systemic chemotherapy. The other patient, a 65-year-old man, developed hypopituitarism and diabetes insipidus 1 year after MM diagnosis. Disease in this patient proved resistant to both radiotherapy and chemotherapy; the patient died 2 years later. These rare complications add new information on the wide spectrum of clinical and laboratory manifestations of MM. It is obvious that descriptions of additional cases are required to better understand the mechanisms of CNS involvement in MM patients.

Entities:  

Mesh:

Year:  2005        PMID: 16019512     DOI: 10.1080/10428190500032661

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  4 in total

1.  Acute vision loss revealing central nervous system aggressive myelomatosis.

Authors:  Georgia Kaiafa; Kyriaki Chalvatzi; Michael D Diamantidis; Virginia Voulgaridou; Ioannis Kostopoulos; Anna Kalogera-Fountzila; Triantafyllia Koletsa; Vaia Bougatsa; Antigoni Archonti; Vasilios Perifanis
Journal:  J Neurol       Date:  2012-09-27       Impact factor: 4.849

2.  Central nervous system myelomatosis with optic neuropathy and intramedullary spinal cord compression responding to radiation therapy.

Authors:  Jenny M Riley; James K Russo; Allison Shipp; Mariam Alsharif; Joseph M Jenrette
Journal:  Jpn J Radiol       Date:  2011-09-01       Impact factor: 2.374

3.  Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice.

Authors:  Artur Jurczyszyn; Norbert Grzasko; Alessandro Gozzetti; Jacek Czepiel; Alfonso Cerase; Vania Hungria; Edvan Crusoe; Ana Luiza Miranda Silva Dias; Ravi Vij; Mark A Fiala; Jo Caers; Leo Rasche; Ajay K Nooka; Sagar Lonial; David H Vesole; Sandhya Philip; Shane Gangatharan; Agnieszka Druzd-Sitek; Jan Walewski; Alessandro Corso; Federica Cocito; Marie-Christine M Vekemans; Erden Atilla; Meral Beksac; Xavier Leleu; Julio Davila; Ashraf Badros; Ekta Aneja; Niels Abildgaard; Efstathios Kastritis; Dorotea Fantl; Natalia Schutz; Tomas Pika; Aleksandra Butrym; Magdalena Olszewska-Szopa; Lidia Usnarska-Zubkiewicz; Saad Z Usmani; Hareth Nahi; Chor S Chim; Chaim Shustik; Krzysztof Madry; Suzanne Lentzsch; Alina Swiderska; Grzegorz Helbig; Renata Guzicka-Kazimierczak; Nikoletta Lendvai; Anders Waage; Kristian T Andersen; Hirokazu Murakami; Sonja Zweegman; Jorge J Castillo
Journal:  Am J Hematol       Date:  2016-04-24       Impact factor: 10.047

4.  Multifocal peripheral nerve involvement associated with multiple myeloma.

Authors:  Yoshikazu Okamoto; Manabu Minami; Eriko Tohno; Izumi Anno; Akira Kunimatshu; Takuya Ueda
Journal:  Skeletal Radiol       Date:  2007-07-26       Impact factor: 2.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.